Search

everythinglearnresearchcommunity

for

Search:↓

Certain plasma proteins and genes are linked to obstructive sleep apnea, suggesting potential new treatments.

Certain SPINK5 gene mutations are common in Israeli families with Comèl-Netherton syndrome.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.

The G allele of IFITM3 rs12252 is linked to more severe COVID-19.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Proteins from Tianshan red deer abomasum have strong anti-inflammatory, anti-tumor, and antioxidant effects.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Dual TCR Treg cells are common in mouse tissues and vary by location.

DNA analysis can help tailor alopecia treatment.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Patients with alopecia areata should be checked for muscle spasms, diarrhea, and ANA to avoid missing Satoyoshi syndrome.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

The research found genetic differences in identical twins that could explain why one twin has a disease while the other does not.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

The document cannot be parsed.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Higher HDAC1 levels in alopecia areata suggest HDAC inhibitors might help treat it and acne.

Two gene areas linked to male pattern baldness found, more research needed.